Tirzepatide: Dual GIP/GLP-1 Receptor Agonists, from Molecular to Clinical Practice for Treating Type-2 Diabetes and Obesity. (2024). InaJEMD - Indonesian Journal of Endocrinology Metabolism and Diabetes, 1(2), 96-110. https://inajemd.pbperkeni.or.id/index.php/journal/article/view/vol1-no2-section12